{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:28:18Z","timestamp":1793600898246,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["KJ2018A171"],"award-info":[{"award-number":["KJ2018A171"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1908085MH270"],"award-info":[{"award-number":["1908085MH270"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuroscience.2026.04.009","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:51:25Z","timestamp":1776383485000},"page":"91-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The protective effect of biochanin A on LPS\/TNF-\u03b1-induced PD models is exerted by regulating ferroptosis through the Sirt1\/Nrf2\/GPX4 signaling pathway"],"prefix":"10.1016","volume":"605","author":[{"given":"Han","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingguang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-9452","authenticated-orcid":false,"given":"Yanyan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.04.009_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.12688\/f1000research.126059.3","article-title":"Mechanisms behind the pharmacological application of biochanin-A: a review","volume":"12","author":"Anuranjana","year":"2023","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.04.009_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12974-022-02400-6","article-title":"Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway","volume":"19","author":"Dang","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.04.009_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041105","article-title":"Chemical and biological properties of biochanin A and its pharmaceutical applications","volume":"15","author":"Feng","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yhbeh.2016.12.009","article-title":"Effect of LPS treatment on tyrosine hydroxylase expression and Parkinson-like behaviors","volume":"89","author":"Girard-Joyal","year":"2017","journal-title":"Horm. Behav."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.04.009_b0030","doi-asserted-by":"crossref","first-page":"e1672","DOI":"10.1212\/WNL.0000000000011630","article-title":"Tumor necrosis factor inhibition and Parkinson disease: a Mendelian randomization study","volume":"96","author":"Kang","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-8994-2_9","article-title":"The open field test for measuring locomotor activity and anxiety-like behavior","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116029","article-title":"Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro","volume":"303","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111763","article-title":"Rotenone induces ferroptosis and neurotoxicity through inhibition of SIRT1-Nrf2-ferroportin 1\/GPX4 pathways in SH-SY5Y cells and mice","volume":"421","author":"Liu","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.04.009_b0050","article-title":"GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.04.009_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12948","article-title":"Melatonin MT1 receptors regulate the Sirt1\/Nrf2\/Ho-1\/Gpx4 pathway to prevent \u03b1-synuclein-induced ferroptosis in Parkinson\u2019s disease","volume":"76","author":"Lv","year":"2024","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.04.009_b0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ncl.2024.12.010","article-title":"Treatment of motor symptoms of Parkinson\u2019s disease","volume":"43","author":"Marsili","year":"2025","journal-title":"Neurol. Clin."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.04.009_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/0113894501320839240918110656","article-title":"Nrf2 and ferroptosis: exploring translational avenues for therapeutic approaches to neurological diseases","volume":"26","author":"Mohan","year":"2025","journal-title":"Curr. Drug Targets"},{"issue":"7","key":"10.1016\/j.neuroscience.2026.04.009_b0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00109-021-02071-5","article-title":"Nrf2 as a potential target for Parkinson\u2019s disease therapy","volume":"99","author":"Niu","year":"2021","journal-title":"J. Mol. Med. (Berl)"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.04.009_b0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/2589977514666220509201804","article-title":"Biochanin-A: a bioactive natural product with versatile therapeutic perspectives","volume":"14","author":"Ramachandran","year":"2022","journal-title":"Curr. Drug Res. Rev."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110777","article-title":"Melatonin reduces radiation-induced ferroptosis in hippocampal neurons by activating the PKM2\/NRF2\/GPX4 signaling pathway","volume":"126","author":"Ren","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2026.150165","article-title":"Programmed cell death pathways in Parkinson\u2019s disease: spotlight on ferroptosis and pyroptosis","volume":"1875","author":"Sharma","year":"2026","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.04.009_b0090","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2174\/0113892010362795250223160707","article-title":"Biochanin-A: a potential candidate for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Singh","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.04.009_b0095","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.ymthe.2025.03.030","article-title":"Recent developments in gene therapy for Parkinson\u2019s disease","volume":"33","author":"Szunyogh","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115636","article-title":"Biochanin A exerts neuroprotective effects in Parkinson\u2019s disease both in vivo and in vitro by improving mitochondrial dysfunction through the Sirt1 signaling pathway","volume":"398","author":"Tian","year":"2026","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115084","article-title":"Acteoside alleviates salsolinol-induced Parkinson\u2019s disease by inhibiting ferroptosis via activating Nrf2\/SLC7A11\/GPX4 pathway","volume":"385","author":"Wang","year":"2025","journal-title":"Exp. Neurol."},{"issue":"24","key":"10.1016\/j.neuroscience.2026.04.009_b0115","article-title":"Pharmacological inhibition of ferroptosis as a therapeutic target for neurodegenerative diseases and strokes","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177104","article-title":"Biochanin A inhibits excitotoxicity-triggered ferroptosis in hippocampal neurons","volume":"985","author":"Won","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.04.009_b0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ncl.2024.12.003","article-title":"Pathogenesis of Parkinson\u2019s disease","volume":"43","author":"Xiao","year":"2025","journal-title":"Neurol. Clin."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.04.009_b0130","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1142\/S0192415X21500750","article-title":"Biochanin A from Chinese medicine: an isoflavone with diverse pharmacological properties","volume":"49","author":"Yan","year":"2021","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0135","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.04.009_b0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/JS9.0000000000002081","article-title":"Translational evaluation of metabolic risk factors impacting DBS efficacy for PD-related sleep and depressive disorders: preclinical, prospective and cohort studies","volume":"111","author":"Yao","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9235358","article-title":"Bioinformatic analysis of genetic factors from human blood samples and postmortem brains in Parkinson\u2019s disease","volume":"2022","author":"Yao","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"30","key":"10.1016\/j.neuroscience.2026.04.009_b0150","article-title":"LRRK2 Gly2019Ser mutation promotes ER stress via interacting with THBS1\/TGF-\u03b21 in Parkinson\u2019s disease","volume":"10","author":"Yao","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102477","article-title":"Ferroptosis in Parkinson\u2019s disease \u2013 the iron-related degenerative disease","volume":"101","author":"Yao","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.04.009_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/biom11070923","article-title":"Kaempferol ameliorates oxygen-glucose deprivation\/reoxygenation-induced neuronal ferroptosis by activating Nrf2\/SLC7A11\/GPX4 axis","volume":"11","author":"Yuan","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0170","article-title":"Mechanisms and regulations of ferroptosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2026.04.009_b0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroscience.2025.09.043","article-title":"Activin A protects against lipopolysaccharide\/TNF-\u03b1 induced damage of dopaminergic neurons both in vivo and in vitro by regulating mitochondrial fusion","volume":"587","author":"Zhang","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.04.009_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2024.103118","article-title":"Quantitative evaluation of hindlimb grip strength in mice as a measure of neuromuscular function","volume":"14","author":"Zheng","year":"2025","journal-title":"MethodsX"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.04.009_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31250","article-title":"LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson\u2019s disease","volume":"239","author":"Zheng","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"23","key":"10.1016\/j.neuroscience.2026.04.009_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313042","article-title":"Targeting ferroptosis in Parkinson\u2019s disease: mechanisms and emerging therapeutic strategies","volume":"25","author":"Zhou","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:46:25Z","timestamp":1793598385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S0306452226002630"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.04.009","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protective effect of biochanin A on LPS\/TNF-\u03b1-induced PD models is exerted by regulating ferroptosis through the Sirt1\/Nrf2\/GPX4 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}